COVID-19 Vaccines Safe, Effective for Patients With Migraine medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.
The U.S. new cases 7-day rolling average are 23.0 % LOWER than the 7-day rolling average one week ago. U.S. hospitalizations due to COVID-19 are now 13.4 %
LOWER than the rolling average one week ago. U.S. deaths due to coronavirus are now 6.1 %
LOWER than the rolling average one week ago. Today s posts include:
U.S. Coronavirus New Cases are 99,511
U.S. Coronavirus hospitalizations are at 71,504
U.S. Coronavirus immunizations have been administered to 13.4 % of the population
The 7-day rolling average rate of growth of the pandemic shows new cases improved, hospitalizations improved, and deaths worsened
Hopefully, these current improving COVID trends will remain in play even with the new strains
email article
No evidence suggests migraine prevention treatment, including monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) pathway or onabotulinumtoxinA (Botox) injections, should be delayed if migraine patients are scheduled to receive a COVID-19 vaccine, experts said.
The established risks of COVID-19 infection and the efficacy of migraine preventive therapies underscore the importance of not delaying either of these interventions, wrote Amy Gelfand, MD, of the University of California San Francisco, and Gregory Poland, MD, director of the Mayo Clinic Vaccine Research Group in Rochester, Minnesota, in an editorial published in We have no data that suggests interference with the COVID-19 response by any of the drugs used in treatment for migraine and other headache disorders, said Poland, the editor-in-chief of